Thrive person-centered planning for young adults with fetal alcohol spectrum disorders
Randomized Controlled Trial of the Thrive Person-Centered Planning Program for Young Adults With FASD
This program tests whether the Thrive person-centered planning helps young adults (18–25) with fetal alcohol spectrum disorders improve goal setting, social support, and quality of life by comparing immediate versus delayed start and individual versus group formats.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 25 Years |
| Sex | All |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Trial ID | NCT07016009 on ClinicalTrials.gov |
What this trial studies
This is a randomized, multi-stage trial that first assigns participants to an immediate or delayed start psychoeducation phase and then re-randomizes them to receive goal-setting in either an individual or group format. The two sequential randomizations create four study arms representing combinations of timing and delivery. Participants complete repeated online assessments over about 10 months to measure goal setting, social support, quality of life, and maintenance of effects. The intervention is delivered through the Thrive program with outcome comparisons across timing and format.
Who should consider this trial
Good fit: Ideal candidates are 18–25 year olds in the United States with a diagnosis of fetal alcohol spectrum disorder or confirmed prenatal alcohol exposure who can use English-language video conferencing.
Not a fit: People without reliable internet or a data plan for video conferencing, or those who cannot communicate in English, are unlikely to be able to participate or benefit.
Why it matters
Potential benefit: If successful, the program could help young adults with FASD set and reach personal goals, strengthen social support, and improve overall quality of life.
How similar studies have performed: Person-centered planning approaches have shown some benefits in other neurodevelopmental and disability contexts, but randomized evidence specifically in young adults with FASD is limited and this design is relatively novel for this population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young adult between the ages of 18 and 25 * Lives in the United States * Has a diagnosis of fetal alcohol spectrum disorder or confirmed prenatal alcohol exposure Exclusion Criteria: * Does not have access to the internet or data plan allowing video conferencing * Is not able to listen or speak in English
Where this trial is running
Rochester, New York
- University of Rochester — Rochester, New York, United States (Recruiting)
Study contacts
- Study coordinator: Christie Petrenko, Ph.D.
- Email: christie_petrenko@urmc.rochester.edu
- Phone: 585-275-2991
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.